MAKERSL — Makers Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹1.10bn
- IN₹1.53bn
- IN₹1.41bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.51 | ||
| Price to Tang. Book | 1.53 | ||
| Price to Free Cashflow | 10.43 | ||
| Price to Sales | 0.74 | ||
| EV to EBITDA | 8.19 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.71% | ||
| Return on Equity | 4.77% | ||
| Operating Margin | 9.57% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 1,266.26 | 1,012.78 | 1,043.89 | 1,207.51 | 1,405.95 | n/a | n/a | 15.42% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +2745.82 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Directors
- Saahil Parikh CEO (42)
- Sandeep Kadam CFO (50)
- Rinku Kholakiya CCO
- Nilesh Jain EDR (46)
- Prashant Godha NED (46)
- Vishal Jain IND (44)
- P. Kathariya IND
- R. Verma IND
- K. Jain NID
- Sudarshan Loyalka NID
- Dipti Shah NID (44)
- Rajeshwar Singh NID
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- July 9th, 1984
- Public Since
- July 13th, 1993
- No. of Shareholders
- 3,484
- No. of Employees
- 114
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 5,900,276
- Address
- 54 D, Kandivli Indl Estate, MUMBAI, 400067
- Web
- https://www.makerslabs.com/
- Phone
- +91 2228688544
- Auditors
- Natvarlal Vepari & Co.
Upcoming Events for MAKERSL
Similar to MAKERSL
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Makers Laboratories share price?
As of Today at 21:53 UTC, shares in Makers Laboratories are trading at IN₹187.02. This share price information is delayed by 15 minutes.
How has the Makers Laboratories share price performed this year?
Shares in Makers Laboratories last closed at IN₹187.02 and the price had moved by over the past 365 days. In terms of relative price strength the Makers Laboratories share price has matched the S&P BSE 100 Index by over the past year.
What are the analyst and broker recommendations for Makers Laboratories?
There is no consensus recommendation for this security.
Find out moreWhat is the Makers Laboratories dividend yield?
Makers Laboratories does not currently pay a dividend.
Does Makers Laboratories pay a dividend?
Makers Laboratories does not currently pay a dividend.
When does Makers Laboratories next pay dividends?
Makers Laboratories does not currently pay a dividend.
How do I buy Makers Laboratories shares?
To buy shares in Makers Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Makers Laboratories?
As of the previous close price of IN₹187.02, shares in Makers Laboratories had a market capitalisation of IN₹1.10bn.
Where are Makers Laboratories shares listed?
Here are the trading details for Makers Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: MAKERSL
What kind of share is Makers Laboratories?
Based on an overall assessment of its quality, value and momentum Makers Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Makers Laboratories share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Makers Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Makers Laboratories. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹187.02, shares in Makers Laboratories were trading -0.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Makers Laboratories PE Ratio?
The Makers Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹187.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Makers Laboratories?
Makers Laboratories' management team is headed by:
- Saahil Parikh - CEO
- Sandeep Kadam - CFO
- Rinku Kholakiya - CCO
- Nilesh Jain - EDR
- Prashant Godha - NED
- Vishal Jain - IND
- P. Kathariya - IND
- R. Verma - IND
- K. Jain - NID
- Sudarshan Loyalka - NID
- Dipti Shah - NID
- Rajeshwar Singh - NID